Mark L. Heaney, MD

Mark L. Heaney, MD

Mark L. Heaney, MD

Specialties: Hematology-Oncology, Medical Oncology, HematologyMore specialties
checkmark iconAccepting new patients
One of America's Top Doctors - Castle Connolly Top Doctors
Rated one of New York Magazine's Best Doctors

Location Info


161 Fort Washington Avenue
New York, NY 10032
US
Other Locations

Additional Locations for Mark L. Heaney, MD

  • 55 Palmer Avenue
    Bronxville, NY 10708
    US

Insurances Accepted


If you do not see your insurance listed, please contact the doctor's office to verify that your insurance is accepted.

  • 1199 National Benefit Fund
  • Aetna
  • Affinity
  • Amerigroup
  • Amida Care
  • Anthem Blue Cross Blue Shield
  • Beechstreet
  • Cigna
  • Connecticare
  • Elderplan FIDA
  • Emblem Health GHI
  • EmblemHealth HIP
  • Empire Blue Cross Blue Shield
  • Fidelis Care
  • Healthcare Partners
  • Healthfirst
  • Medicaid
  • Medicare
  • Multiplan
  • MVP Health Care
  • Oxford Freedom
  • Oxford Medicare Advantage
  • Pacificare National
  • Unicare
  • UnitedHealthcare
  • UnitedHealthcare COMMUNITY PLAN
  • VNSNY CHOICE
  • WellCare

About Mark L. Heaney, MD


Mark Heaney received his undergraduate education at Harvard and graduate education at the University of Virginia where he received an M.D. and a Ph.D. in microbiology. After Internal Medicine residency at SUNY Stony Brook, he had fellowship training in Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Heaney subsequently joined the faculty at Memorial Sloan-Kettering Cancer Center. As a member of the Leukemia Service for nearly 20 years, Dr. Heaney continued laboratory research, initially studying the cell surface receptors that govern white blood cell development and leukemia cell growth. More recently, he has focused on metabolic differences between leukemia...
Mark Heaney received his undergraduate education at Harvard and graduate education at the University of Virginia where he received an M.D. and a Ph.D. in microbiology. After Internal Medicine residency at SUNY Stony Brook, he had fellowship training in Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Heaney subsequently joined the faculty at Memorial Sloan-Kettering Cancer Center. As a member of the Leukemia Service for nearly 20 years, Dr. Heaney continued laboratory research, initially studying the cell surface receptors that govern white blood cell development and leukemia cell growth. More recently, he has focused on metabolic differences between leukemia cells and normal cells that can provide insight into how leukemias behave in the individual patient and how they respond to treatment. His finding that vitamin C has the potential to blunt the beneficial effects of chemotherapy has been widely cited.Dr. Heaney has also been an active clinical investigator. He has been the Principal Investigator of many clinical trials that have aimed at developing new treatments for leukemia. In particular, he has focused on new treatments of the myeloproliferative neoplasms, primary myelofibrosis, polycythemia vera and essential thrombocythemia, but has also studied new treatments for chronic myeloid leukemia, mastocytosis and Langerhans cell histiocytosis in keeping with his clinical expertise in rare blood cancers.Dr. Heaney joined the faculty at CUMC in January, 2013. He has continued his commitment to caring for patients with blood cancers, developing new treatments including cutting edge clinical trials, and laboratory research that concentrates on translating discoveries from the bench to the bedside. He also renewed his investment in medical education, becoming Director of the Hematology and Medical Oncology Fellowship Program in 2014.

Hospital Affiliations

  • NewYork-Presbyterian Columbia University Irving Medical Center
  • NewYork-Presbyterian Lawrence Hospital

Expertise

  • Acute Leukemia
  • Acute Lymphocytic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Cancer Care
  • Chronic Leukemia
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia
  • Essential Thrombocythemia
  • Hairy Cell Leukemia
  • Hematologic Malignancy
  • Histiocytosis
  • Immune Thombocytopenic Purpura
  • Large Granular Lymphocytic Leukemia
  • Leukemia
  • Lymphoblastic Leukemia
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Myeloproliferative Disease
  • Polycythemia Vera
  • Waldenstrom's Disease

Board Certifications

  • Hematology
  • Medical Oncology

Awards


  • 1990                              American Cancer Society Clinical Fellow
  • 1992                              Sloan-Kettering Clinical Scholar, Charles A. Dana Fellow
  • 1993-1996                  NIH Physician Scientist Award
  • 1996-2001                  Catherine and Frederick R. Adler Chair for Junior Faculty
  • 1998-2001                  Translational Research Award, Leukemia and Lymphoma Society
  • 1999                              Who’s Who In America
  • 2001                              Hematology Fellows Attending Teaching Award, Memorial Sloan-Kettering
  • 2002                              Meet the Professor, ACP-ASIM Annual Meeting
  • 2008                              Abstract Reviewer and Oral Session Chair, ASH Annual Meeting
  • 2014                              Fellow, American College of Physicians

GET AN EXPERT SECOND OPINION

Learn More